 |
November,20 2008 |
|
Phase II US clinical trial- Involving
Hong Kong hospital
Article in Newspaper
"Nikkei Sangyo Shimbun" |
|
November 11 , 2008 |
|
Exterminate incurable diseases by
high-tech
Article in Newspaper
"Nikkei Sangyo Shimbun" |
|
October,15 2008 |
|
Mebiopharm enters into Phase Ⅱ study
of MBP-426 in US
Article in Newspaper
"Nikkei Sangyo Shimbun" |
|
October 02, 2008 |
|
Phase I study of anticancer
DDS in US shown good result; starting Phase II targeting colon
cancer
Nikkei
Biotech online |
|
April 28, 2008 |
|
A collaborative assignment with Keio
University (Assistant Prof. Masakazu Ueda, Graduate School of
Medicine; Prof. Haruma Kawaguchi, Science and Technology) and
Tokyo Institute of Technology (Prof. Hiroshi Handa, Bioscience
and Biotechnology; Prof. Masanori Abe, Physical Electronics)
on diagnosis and treatment system development against breast
cancer was adopted as Comprehensive Support Programs by Japan
Science and Technology Agent
|
|
October 25, 2007 |
|
Presentation on Open Label Phase 1
Study of MBP-426 at the AACR-NCI-EORTC International
Conference in San Francisco |
|
April 25, 2007 |
|
Raised 9th round finance of Yen
357.9Million
|
|
April 18, 2007 |
|
Presentation at American Association
for Cancer Research (AACR) Annual Meeting 2007 in Los Angeles
◆MBP-426
◆MBP-Y003 |
|
April 09, 2007 |
|
2nd tumor-targeting product is to
enter clinical trial in November
Article in Newspaper
"Nikkei Sangyo Shimbun" |
|
March 28, 2007 |
|
Raised 8th round finance of Yen
600.9Million
|
|
February 01, 2007 |
|
Mebiopharm ventures into CMO,
manufacturing liposome, GLP in summer
Nikkei
Biotech online |
|
January 24, 2007 |
|
Nanotech DDS drugs - Domestic power
matching US companies with new technology
Article in Newspaper
"Nikkei Sangyo Shimbun" |
|
Oct. 27, 2006 |
|
New method of DDS - Domestic power
leading cancer treatment
Nikkei Sangyo
Shinbun |
|
Sep. 28, 2006 |
|
Obtain exclusive sales agreement for
Transferrin
Nikkei Sangyo
Shinbun
|
|
September 27, 2006 |
|
Obtain exclusive supply and
sales agreement for Transferrin from Blood supply Netherlands;
using anti cancer drug containing Oxaliplatin
Nikkei
Biotech online |
|
Aug. 28, 2006 |
|
Technologies Frontier - targeting to
the tumor
Nikkei Business
2006.8.28 issue |
|
July 25, 2006 |
|
Hot technologies - Nanotechnology
targeting to the tumor
Nikkei Sangyo
Shinbun |
|
June 29, 2006 |
|
A new formulation targeting to the
tumor
Nikkei Sangyo
Shinbun |
|
May 8, 2006 |
|
Nanotechnologies formulation capsule
zeros in on the cancer
Nikkei Sangyo
Shinbun |
|
April 27, 2006 |
|
Mebiopharm joined an international
Bio VB group
Nikkei Sangyo
Shinbun |
|
April 26, 2006 |
|
Anticancer nanotechnology drug agent
begins clinical trial in US
Nikkei Sangyo
Shinbun |
|
April 25, 2006 |
|
Measure expression level of
target molecules, aiming for early ratification to enter Phase
I study in US
Nikkei
Biotech online |
|
March 27, 2006 |
|
Nanotechnology New
Medication
Nikkei Sangyo
Shinbun |
|
April 26, 2006 |
|
Mebiopharm enters into an exclusive
license agreement with NOF Corporation regarding its tumor
targeting platform technology
Nikkei
Shinbun |
|
December 13, 2005 |
|
Mebiopharm grant exclusive DDS
production and sales to NOF cooperation; using anti cancer
drug containing Oxaliplatin
Nikkei
Biotech online |
|
September 06, 2005 |
|
Apply for starting of clinical
trial of new drug in US, using DDS anticancer drug; using anti
cancer drug containing Oxaliplatin
Nikkei
Biotech online |
|
August 9, 2005 |
|
Mebiopharm produces DDS anti-tumor
drug in the US and Asia
Nikkan Kogyo
Shinbun |
|
June 27, 2005 |
|
New drug targeting affected organ - shown in the
studies
Nikkei Shinbun
|
|
June 02, 2005 |
|
Apply for initiating clinical
trial in US in summer – using anti cancer drug containing
Oxaliplatin
Nikkei
Biotech online |
|
March 18, 2005 |
|
Early promise for Mebiopharm's
liposomal Oxaliplatin
Scrip ＊ World pharmaceutical
news in U.K. |
|
February 22, 2005 |
|
Presentation at AACR - DDS
technology for colorectal cancer
Nikkan Kogyo
Shinbun |
|
February 21, 2005 |
|
Anticancer DDS agent to begin
clinical trial in US this autumn
The Chemical
Daily |
|
February 17, 2005 |
|
Presentation at AACR
Pre-clinical study for Transferrin –modified PEG liposome
containing Oxaliplatin
Nikkei Biotech online |
|
February 17, 2005 |
|
Presentation at AACR
Pre-clinical study for Transferrin –modified PEG liposome
containing Oxaliplatin In its effort to advance the
adaptation of DDS technology to the development of anticancer
company, we have prepared a presentation
Nikkan Yakugyo
|
|
February 16, 2005 |
|
Presentation at AACR
“Pre-Clinical Study for Transferrin-modified PEG liposome
containing Oxaliplatin” >>Click
|
|
October 18, 2004 |
|
Manufacturing industry ―
competitiveness borne of knowledge |
|
|
|
Nikkei Sangyo Shimbun |
|
September 13, 2004 |
|
Silicon Valley branch office opened |
|
September 2, 2004 |
|
NHK's "Ohayo Nippon" program on
TV |
|
August 18, 2004 |
|
Carry out third-party
allocation |
|
|
|
Nikkei Shinbun |
|
August 10, 2004 |
|
Established U.S. office to develop new colon cancer
drug |
|
|
|
|
|
July 27, 2004 |
|
Attacking a cancer's source of
nutrition: Applies to patent immunotherapeutic
technique
Nikkei Sangyo
Shimbun |
|
July 19, 2004 |
|
Mebiopharm receives JETRO
startup assistance in Silicon Valley -- first to move into the
biotech industry
Nikkan Kogyo
Shimbun |
|
26 May, 2004 |
|
New cancer medicine delivered directly to diseased
site
Commercially available as early as 2007 in
U.S.
Nikkei
Sangyo Shimbun, p. 1 |
|
20 May, 2004 |
|
Universities that create wealth: new venture from
The Tokyo University
Nikkei Sangyo Shimbun |
|
May, 2004 |
|
New cancer drug developed that delivers medicine
directly to diseased site
Nikkei Net Advanced
Medicine |
|
10 March, 2004 |
|
First Alliance Promotion -- message from Akamaru
Venture Participation |
 P |
March 2004 |
|
NIF Ventures Ltd. Nif news March
edition |
